Organisation
Department of Pharmaceutics
Department
Current researchers
81 - 90 of 120 results
- Karen Peynshaert (Member)
- Luc Pieters (Member)
- Deep Punj (Member)
- Thibaut Quennesson (Member)
- Koen Raemdonck (Member)
- Jana Ramon (Member)
- Katrien Remaut (Member)
- Jean Paul Remon (Member)
- Martijn Risseeuw (Member)
- Vera Rogiers (Member)
Projects
81 - 90 of 375
- High drug-loaded pellets for dysphagia and sustained releaseFrom1 May 2022 → TodayFunding: IOF - technology validation in real environment
- Modular high-end mass spectrometer for ultrasensitive quantification and imaging of small organic molecules in cross-health research - MSsmall-XHFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Multifunctional processing equipment for both conventional and reactive twin screw extrusion (MultiProc)From1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- In vivo evaluation of the expression kinetics and immunogenicity of lipid nanoparticle mediated messenger RNA and self-amplifying messenger RNA delivery to the retinaFrom18 Apr 2022 → 17 Apr 2023Funding: Foundations, funds and other with scientific goal
- The generation of bona fide T cell precursors for cell therapyFrom15 Apr 2022 → TodayFunding: IOF - technology validation in lab
- Benchfee Eline SoetensFrom1 Mar 2022 → TodayFunding: IOF - mandates
- Universal antibody scaffolds with drug-like features for straightforward mini-domain graftingFrom1 Feb 2022 → TodayFunding: BOF - projects
- Toekenning: ARVO Foundation for Eye Research and the Eye Bank Association of America EyeFind Research: "Grant Karen Peynshaert"From1 Feb 2022 → 31 Jan 2023Funding: Foreign Nonprofit organisations and equivalents
- Light for life: high contrast multimodal medical imaging using inorganic fluorophoresFrom1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Migration, diet and health of the first permanent settlers of Belgium: inter- and multi-disciplinary perspectivesFrom1 Jan 2022 → TodayFunding: BOF - projects
Publications
1 - 10 of 1925
- Synthesis and potency of novel uracil nucleotides and derivatives as P2Y(2) and P2Y(6) receptor agonists(2008)
Authors: HJ Ko, RL Carter, Liesbet Cosyn, R Petrelli, S de Castro, P Besada, YX Zhou, L Cappellacci, P Franchetti, M Grifantini, et al.
Pages: 6319 - 6332 - Human mitochondrial thymidine kinase is selectively inhibited by 3'-thiourea derivatives of beta-thymidine: identification of residues crucial for both inhibition and catalytic activity(2009)
Authors: Jan Balzarini, Ineke Van Daele, Ana Negri, Nicola Solaroli, Anna Karlsson, Sandra Liekens, Frederico Gago, Serge Van Calenbergh
Pages: 1127 - 1136 - ERS guidelines, statements and technical standards published in the ERJ in 2014: a year in review(2015)
Authors: Guy Brusselle, Mina Gaga
Pages: 863 - 866 - Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status(2012)
Authors: Guy Brusselle, Rudi Peché, Paul Van den Brande, Albert Verhulst, Wim Hollanders, Jacques Bruhwyler
Pages: 811 - 819 - Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns(2014)
Authors: David Price, Daniel West, Guy Brusselle, Kevin Gruffydd-Jones, Rupert Jones, Marc Miravitlles, Andrea Rossi, Catherine Hutton, Valerie L Ashton, Rebecca Stewart, et al.
Pages: 889 - 905 - Integrating real-life studies in the global therapeutic research framework(2013)
Authors: Nicolas Roche, Helen K Reddel, Alvar Agusti, Eric D Bateman, Jerry A Krishnan, Richard J Martin, Alberto Papi, Dirkje Postma, Mike Thomas, Guy Brusselle, et al.
Pages: e29 - e30 - The significance of eosinophilic inflammation in chronic obstructive pulmonary disease(2018)
Authors: Christopher B Cooper, Guy Brusselle, Steven J Pascoe, Ian D Pavord
Pages: 967 - 968 - InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients: the LIAISON study protocol(2013)
Authors: Fulvio Braido, Guy Brusselle, Eleonora Ingrassia, Gabriele Nicolini, David Price, Nicolas Roche, Joan B Soriano, Heinrich Worth
- Risk of a biased assessment of the evidence when limiting literature searches to the English language : macrolides in asthma as an illustrative example(2015)
Authors: Guy Brusselle, Francesco Blasi
Pages: 109 - 110 - Exacerbation rate reduction according to baseline blood eosinophilic count in patients with asthma treated with ICS/LABA maintenance and reliever therapy(2019)Volume: 199
Authors: Guy Brusselle, A Papi, G Nicolini, L Santoro, D Guastalla
Number of pages: 1